0001593968-21-002312.txt : 20211029
0001593968-21-002312.hdr.sgml : 20211029
20211029201605
ACCESSION NUMBER: 0001593968-21-002312
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210125
FILED AS OF DATE: 20211029
DATE AS OF CHANGE: 20211029
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waltz Todd
CENTRAL INDEX KEY: 0001383895
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36475
FILM NUMBER: 211364936
MAIL ADDRESS:
STREET 1: P O BOX 1445
CITY: CUPERTINO
STATE: CA
ZIP: 95015
FORMER NAME:
FORMER CONFORMED NAME: WELTZ TODD
DATE OF NAME CHANGE: 20061218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AEMETIS, INC
CENTRAL INDEX KEY: 0000738214
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 261407544
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20400 STEVENS CREEK BLVD
STREET 2: SUITE 700
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: 408-517-3304
MAIL ADDRESS:
STREET 1: 20400 STEVENS CREEK BLVD
STREET 2: SUITE 700
CITY: CUPERTINO
STATE: CA
ZIP: 95014
FORMER COMPANY:
FORMER CONFORMED NAME: AE BIOFUELS, INC.
DATE OF NAME CHANGE: 20110714
FORMER COMPANY:
FORMER CONFORMED NAME: AE Biofuels, Inc.
DATE OF NAME CHANGE: 20071212
FORMER COMPANY:
FORMER CONFORMED NAME: MARWICH II LTD
DATE OF NAME CHANGE: 19840123
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2021-01-25
0000738214
AEMETIS, INC
AMTX
0001383895
Waltz Todd
20400 STEVENS CREK BLVD, SUITE 700
CUPERTINO
CA
95014
false
true
false
false
Executive Vice President, CFO
Common Stock
2021-01-26
4
S
false
10000
9.609
D
165401
D
Common Stock
2021-01-25
4
S
false
10000
7.1135
D
165401
D
Common Stock
2021-01-29
4
S
false
10000
6.57
D
165401
D
Common Stock
2021-02-01
4
S
false
10000
7.91
D
165401
D
Common Stock
2021-02-02
4
S
false
10000
8
D
165401
D
Common Stock
2021-02-03
4
S
false
10000
7.53
D
165401
D
Common Stock
2021-02-04
4
S
false
10000
7.86
D
165401
D
Common Stock
2021-02-05
4
S
false
10000
7.45
D
165401
D
Common Stock
2021-02-08
4
S
false
10000
7.59
D
165401
D
Common Stock
2021-02-09
4
S
false
10000
7.25
D
165401
D
Common Stock
2021-02-10
4
S
false
10000
7.31
D
165401
D
Common Stock
2021-02-11
4
S
false
10000
7.71
D
165401
D
Common Stock
2021-02-12
4
S
false
10000
7.24
D
165401
D
Common Stock
2021-02-16
4
S
false
10000
7.8
D
165401
D
Common Stock
2021-02-17
4
S
false
10000
8.8
D
165401
D
Common Stock
2021-02-18
4
S
false
10000
8.07
D
165401
D
Common Stock
2021-02-19
4
S
false
10000
8.15
D
165401
D
Common Stock
2021-02-22
4
S
false
10000
8.27
D
165401
D
Common Stock
2021-03-15
4
F
false
4955
20.83
D
240446
D
Common Stock
2021-03-15
4
S
false
26000
19.9231
D
194446
D
Common Stock
2021-03-17
4
S
false
455
19.5437
D
214840
D
Common Stock
2021-03-17
4
F
false
5106
18.42
D
215295
D
Common Stock
2021-04-19
4
F
false
3649
18.99
D
242209
D
Common Stock
2021-04-19
4
S
false
51170
19.6681
D
191039
D
Common Stock
2021-04-22
4
S
false
23099
19.3969
D
167940
D
Common Stock
2021-01-27
4
S
false
10000
7.77
D
165401
D
Common Stock
2021-01-28
4
S
false
10000
7.5281
D
165401
D
Common Stock
2021-03-16
4
S
false
29045
19.5437
D
165401
D
Common Stock
2021-03-17
4
S
false
46900
18.9162
D
167940
D
These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.
These shares were sold pursuant to a Rule 10b5-1 plan.
As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.
These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.
/s/ Todd Waltz
2021-10-29